This working paper presents the results of a 2006 survey of pharmacy directors at rural hospitals currently participating in the 340B drug pricing program. It examines the perspectives of pharmacy directors at participating rural hospitals, explores the financial impact of the program, and identifies specific program features that present barriers to its broader implementation. The working paper includes tables, references, and an appendix.
|